The negative affective symptoms of opiate withdrawal powerfully motivate drug-seeking behavior and may trigger relapse to heroin abuse. To date, no medications exist that effectively relieve the negative affective symptoms of opiate withdrawal. The corticotropin-releasing factor (CRF) system has been hypothesized to mediate the motivational effects of drug dependence. The CRF signal is transmit...

Much research has focused on the opiate properties of dynorphin, especially toward differentiating its binding to various receptor sub-populations. The effects of dynorphin in vitro have clearly documented its opiate binding potential. However, central administration of dynorphin produces behavioral and electrophysiological effects unlike those of classical ~t-, Kor 8-receptor agonists. In fact...

Opiate alkaloid and opioid peptide actions on spontaneous neuronal activity and postsynaptic amino acid responsiveness were assessed using intracellular recording techniques applied to murine spinal cord neurons in primary dissociated cell culture. Application of opiates was by superfusion and amino acids by iontophoresis. Glycine and GABA but not glutamate responses were antagonized by the opi...

The molecular nature and configuration of the opiate receptor is a problem under intensive investigation in a number of laboratories (1,2,3). Our interest in the problem developed as a result of a finding of others (4) that a proteolipid fraction from brain may be responsible for stereospecific opiate binding observed in various preparations of brain tissue. Upon examining various lipids, prote...